Document is current
Any future updates will be listed below
-
Authors
Fassio, Angelo https://orcid.org/0000-0001-9187-232X
Andreola, Stefano
Gatti, Davide
Pollastri, Francesco
Gatti, Matteo
Fabbrini, Paolo
Gambaro, Giovanni
Ferraro, Pietro Manuel
Caletti, Chiara
Rossini, Maurizio
Viapiana, Ombretta
Bixio, Riccardo
Adami, Giovanni
-
Funding
Funding for this research was provided by:
Università degli Studi di Verona
- License Information
-
More Information
Article History
Received: 12 December 2023
Accepted: 16 April 2024
First Online: 10 May 2024
Declarations
:
: DG has received advisory board honoraria, consultancy fees and/or speaker fees from Amgen, Celgene, Eli-Lilly, MSD-Italia, Organon, UCB. MR has received advisory board honoraria, consultancy fees and/or speaker fees from Abiogen, Amgen, Abbvie, BMS, Celgene, Eli-Lilly, Galapagos, Grunenthal, MSD, Novartis, Pfizer, Sanofi, Sandoz, Theramex, UCB. GG has received speaker and advisory board honoraria from Vifor Pharma. PMF received consultant fees and grant/other support from Allena Pharmaceuticals, Alnylam, Amgen, AstraZeneca, Bayer, BioHealth Italia, Gilead, Novo Nordisk, Otsuka Pharmaceuticals, Rocchetta, Vifor Fresenius, and royalties as an author for UpToDate. All other Authors declare no conflict of interest.
: The study was conducted within the protocol 1483CESC approved by our local Ethics Committee, in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The clinical and research activities being reported are consistent with the Principles of the Declaration of Istanbul as outlined in the “Declaration of Istanbul on Organ Trafficking and Transplant Tourism”. Written informed consent was obtained from all participants included.
